As GBM cells are developmentally immature and retain neural stem cell features, they express several stem cell markers such as SOX2, CD44, NESTIN, PROMININ, etc., which critically regulate their tumorigenicity [25]. The gene discussed is SOX2; the disease is glioblastoma.